vanadium has been researched along with Acute Promyelocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chumakov, Y; Gulea, A; Julea, F; Pahontu, E; Petrenco, P; Purcarea, V; Rosu, T | 1 |
| Durham, RW; Hall, IH; Mueller, S; Ramachandran, BM; Sneddon, LG; Tram, M | 1 |
2 other study(ies) available for vanadium and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
Antibacterial, antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacillus cereus; Candida albicans; Cell Proliferation; Coordination Complexes; Copper; Crystallography, X-Ray; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Escherichia coli; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Spectroscopy; Metals; Microbial Sensitivity Tests; Molecular Structure; Nickel; Salmonella; Staphylococcus aureus; Thiosemicarbazones; Vanadium | 2015 |
Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Caspase Inhibitors; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Niobium; Organometallic Compounds; Topoisomerase I Inhibitors; Vanadium | 2003 |